BioSyent Inc. | |
Stock Exchange | Other OTC |
EPS |
$0.29 |
Market Cap |
$67.79 M |
Shares Outstanding |
14.52 M |
Public Float |
- |
BioSyent Inc. | |
Stock Exchange | Toronto Ventures Stock Exchange |
EPS |
CAD0.38 |
Market Cap |
CAD88.82 M |
Shares Outstanding |
13.84 M |
Public Float |
11.35 M |
Address |
170 Attwell Drive Toronto Ontario M9W 5Z5 Canada |
Employees | - |
Website | http://www.biosyent.com |
Updated | 07/08/2019 |
BioSyent, Inc. is a specialty pharmaceutical company, which engages in the development of pharmaceutical and healthcare products. Its products include FeraMAX 150, Cathejell Jelly, FeraMAX Powder, RepaGyn, Proktis-M, Aguettant System, and Cysview. The company was founded on April 28, 1947 and is headquartered in Ontario, Canada. |